BellaSeno Starts Two Clinical Trials of its Resorbable Breast and Chest Implants
Resorbable implants to treat pectus excavatum and silicone breast implant revision / congenital defect correction Fi…
Resorbable implants to treat pectus excavatum and silicone breast implant revision / congenital defect correction Fi…
Successful initial treatment of pectus excavatum patient in Australia Data published in the European Journal of Plastic…
BellaSeno GmbH, an ISO 13485-certified medtech company developing absorbable scaffolds using additive manufacturing tech…
Winner of the Australian Global Innovation Linkages Program Funding dedicated to advancing regenerative scaffolds for br…
. Collaboration with Fraunhofer IZI further expanded Funding provided by Sächsische Aufbaubank BellaSeno GmbH, an I…
BellaSeno GmbH, an ISO 13485-certified medtech company developing absorbable scaffolds using additive manufacturing tech…
Funding dedicated to the development of commercial-scale, fully automated additive manufacturing of resorbable medical i…
. - Seamless transition from R&D to commercial-scale additive manufacturing - Leading-edge cleanroom, no-touch manufac…
First patient with Pectus Excavatum congenital defect has undergone surgery in Australia Minimally invasive procedure an…
BellaSeno GmbH, an ISO 13485-certified medtech company developing absorbable scaffolds using additive manufacturing tech…